|PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : firstname.lastname@example.org / email@example.com
Index Copernicus ICV 2015: 85.95
NAAS RATING 2017: 5.38
Extended-spectrum β-lactamase (ESBL) continues to be a major problem in healthcare settings. The current study was carried out to assist the clinicians to prescribe appropriate antibiotics against gram-negative clinical isolates. Different Proteus species are commonly implicated pathogens in hospital as well as community acquired infections. A total of 172 Proteus species isolated from exudates and urine were speciated and tested for antibiogram. ESBL screening was done using 3rd generation Cephalosporin’s and confirmed by double disc diffusion test. Among the 172 Proteus isolates, exudates (68.02%) showed the predominant cases, with Proteus mirabilis 117(62.20%) as predominant isolated organism followed by Proteus vulgaris 56 (32.55%), Providencia stuartii 6 (3.48%) and Morganella morganii 3 (1.74%). They were highly sensitive to Imipenem. Proteus species were highly resistant to ampicillin, Ceftazidime, Aminoglycosides and Quinolones showing 70% of multiple drug resistant (MDR) and 3.4% Pan drug resistant (PDR) of which 24% of Proteus isolates were confirmed ESBL producers.